Cost-effectiveness of drug treatment for young and middle-aged stage 1 hypertensive patients with high risk-Reference-Cited by-同舟云学术

Cost-effectiveness of drug treatment for young and middle-aged stage 1 hypertensive patients with high risk

Published:2023-11-24 Issue: Volume:13 Page:
ISSN:2047-2978
Container-title:Journal of Global Health
language:
Short-container-title:J Glob Health

Author:

Zhou Yan-Feng¹,Deng Hua²,Wang Guo-Dong³,Chen Shuohua³,Xing Aijun³,Wang Yanxiu³,Zhao Haiyan³,Gao Jingli⁴,Wu Shouling³

Affiliation:

1. Department of Social Medicine, School of Public Health, Guangxi Medical University, Nanning, China

2. Department of Nephrology, The First People's Hospital of Chenzhou, Chenzhou, China

3. Department of Cardiology, Kailuan General Hospital, Tangshan, China

4. Department of Intensive Care Unit, Kailuan General Hospital, Tangshan, China

Publisher

International Society of Global Health

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference36 articles.

1. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.;Whelton;Hypertension,2018

2. 2018 ESC/ESH Guidelines for the management of arterial hypertension.;Williams;Eur Heart J,2018

3. 2020 International Society of Hypertension global hypertension practice guidelines.;Unger;J Hypertens,2020

4. 2018 Chinese guidelines for the management of hypertension.;Liu;Chin J Cardiovasc Med.,2019

5. World Health Organization. Guideline for the pharmacological treatment of hypertension in adults. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.